JFG
ROIV icon

Jefferies Financial Group’s Roivant Sciences ROIV Stock Holding History

Jefferies Financial Group’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-7,266
Closed -$201K – 1998
2026
Q1 		$201K Sell
7,266
-3,507,567
-100% -$90.1M ﹤0.01% 1525
2025
Q4 		$76.3M Buy
+3,514,833
New +$69.3M 0.39% 40
2025
Q1 		– Sell
-40,000
Closed -$473K – 1943
2024
Q4 		$473K Buy
+40,000
New +$473K ﹤0.01% 1118
2024
Q3 		– Sell
-132,500
Closed -$1.4M – 1717
2024
Q2 		$1.4M Buy
+132,500
New +$1.45M 0.01% 649
2023
Q3 		– Sell
-50,000
Closed -$504K – 1941
2023
Q2 		$504K Sell
50,000
-12,500
-20% -$112K ﹤0.01% 1175
2023
Q1 		$461K Buy
+62,500
New +$515K ﹤0.01% 1117

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
QF
QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Jefferies Financial Group's ROIV Position: Q2 2026 in Review

Jefferies Financial Group sold out of Roivant Sciences (ROIV) in Q2 2026, closing a stake of 7,266 shares — an estimated $201K sold.

Jefferies Financial Group first reported a position in ROIV in Q1 2023 and held it in 6 quarters. The position peaked at $76.3M in Q4 2025. 498 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

  • Jefferies Financial Group reported no remaining Roivant Sciences position as of Q2 2026 after selling out during the quarter.
  • Jefferies Financial Group sold 7,266 Roivant Sciences shares in Q2 2026, an estimated $201K.
  • Jefferies Financial Group first reported a position in Roivant Sciences in Q1 2023 and held it in 6 quarters.
  • Jefferies Financial Group's Roivant Sciences position peaked at $76.3M in Q4 2025.
  • 498 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on Jefferies Financial Group's 13F filing for Q2 2026, filed 17 Aug 2026.